Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Total Liabilities (2016 - 2025)

Bio-Techne (TECH) has 16 years of Total Liabilities data on record, last reported at $511.7 million in Q4 2025.

  • For Q4 2025, Total Liabilities fell 13.55% year-over-year to $511.7 million; the TTM value through Dec 2025 reached $511.7 million, down 13.55%, while the annual FY2025 figure was $639.1 million, 0.64% up from the prior year.
  • Total Liabilities reached $511.7 million in Q4 2025 per TECH's latest filing, down from $560.3 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $767.2 million in Q4 2023 and bottomed at $511.7 million in Q4 2025.
  • Average Total Liabilities over 5 years is $627.3 million, with a median of $612.8 million recorded in 2021.
  • Peak YoY movement for Total Liabilities: fell 24.17% in 2021, then soared 43.05% in 2023.
  • A 5-year view of Total Liabilities shows it stood at $602.3 million in 2021, then fell by 10.96% to $536.3 million in 2022, then skyrocketed by 43.05% to $767.2 million in 2023, then decreased by 22.84% to $591.9 million in 2024, then fell by 13.55% to $511.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Total Liabilities were $511.7 million in Q4 2025, $560.3 million in Q3 2025, and $639.1 million in Q2 2025.